Evidence map›Paper›PMID 40951573›Full record

ArticleArchives of Razi Institute2025

The Study of Mutations and Phylogenetics of the SARS-CoV-2 Spike Gene in Population from Tehran Province.

M Mohamadzadeh, H Keyvani, A M Latifi, F Keyvani, M R Azizi, M M Ranjbar, G H Karimi

Abstract read
In one paragraph

Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M MohamadzadehApplied Biotechnology Research Center, Baqiyatallah University of Medical Science, Tehran, Iran.
H KeyvaniDepartment of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
A M LatifiApplied Biotechnology Research Center, Baqiyatallah University of Medical Science, Tehran, Iran.
F KeyvaniDepartment of Electrical and Computer Engineering, Faculty of Engineering, University of Waterloo, Waterloo, ON N2L, Canada.
M R AziziDepartment of Microbiology, Faculty of Sciences, Islamic Azad University, Karaj Branch, Karaj, Iran.
M M RanjbarRazi Vaccine and Sera research institute, Agricultural Research, Education.
G H KarimiRazi Vaccine and Sera research institute, Agricultural Research, Education.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In December 2019, an outbreak of pneumonia of unknown etiology was reported in Wuhan, China. The virus, known as SARS-CoV-2, is contagious and infects the lower respiratory tract. Since various coherent research needs to be conducted in Iran to detect mutations in the SARS-CoV-2 S gene, the present study was conducted to determine the sequence, mutation pattern, and phylogenetic evaluation of this gene. To this end, 120 positive samples were included in the study to evaluate the complete S gene sequence by Reverse transcriptase-PCR.Subsequent to the sequencing process, the gene assembly, blasting, mutation analysis, and phylogenetic analysis were performed using MEGA-X.A total of 161 mutations were observed in the S gene sequences of Iran. The results of the phylogenetic tree showed that all the S gene sequences of Iranian samples were divergent from the Wuhan strain and had the most similarity to it and also alpha variants. 161 nonsynonymous variations were found along the complete coding S gene with a high frequency of A262T, D614G, and P863H, which were embedded in HVR1, HVR2, and HVR3, respectively. The majority of highly variable fragments have been identified in the loop secondary structure of protein. In the present study, the predominant variants (predominantly alpha variants) and mutations were observed to be in parallel with the evolution of the virus and its fitness. A comprehensive overview of the genetic mutation of the first three waves of SARS-CoV-2 in Iran was provided, which could be used to make significant decisions and take effective measures in future pandemics to develop vaccines, kits and effective therapeutics.

Indexed as

SARS-CoV-2Spike Glycoprotein, CoronavirusCOVID-19Genetic VariationHumansIranMutationPhylogenyProtein SubunitsProtein SubunitsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2MutationPhylogenetic AnalysisSARS-CoV-2S Gene

Identifiers

PMID40951573
PMCPMC12428882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.